Evidence map›Paper›PMID 25934101›Full record

ArticleMolecular neurobiology2016

Neurobeachin Regulates Glutamate- and GABA-Receptor Targeting to Synapses via Distinct Pathways.

F Farzana, R Zalm, N Chen, K W Li, Seth G N Grant, A B Smit, R F Toonen, M Verhage

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. GABASynapse (New York, N.Y.) · 2026
    Review
  3. Article
  4. Proteostasis regulation of GABABiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Review
  5. Review
  6. Article
  7. Frontiers in neuroscience · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

F FarzanaDepartment of Functional Genomics, Centre for Neurogenomics and Cognitive Research (CNCR), Neuroscience Campus Amsterdam, VU Medical Centre, VU University Amsterdam, 1081HV, Amsterdam, The Netherlands.
R ZalmDepartment of Functional Genomics, Centre for Neurogenomics and Cognitive Research (CNCR), Neuroscience Campus Amsterdam, VU Medical Centre, VU University Amsterdam, 1081HV, Amsterdam, The Netherlands.
N ChenDepartment of Molecular and Cellular Neurobiology, Centre for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University Amsterdam, 1081HV, Amsterdam, The Netherlands.
K W LiDepartment of Molecular and Cellular Neurobiology, Centre for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University Amsterdam, 1081HV, Amsterdam, The Netherlands.
Seth G N GrantCentre for Clinical Brain Sciences, Edinburgh University, Edinburgh, EH16 4SB, United Kingdom.
A B SmitDepartment of Molecular and Cellular Neurobiology, Centre for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University Amsterdam, 1081HV, Amsterdam, The Netherlands.
R F ToonenDepartment of Functional Genomics, Centre for Neurogenomics and Cognitive Research (CNCR), Neuroscience Campus Amsterdam, VU Medical Centre, VU University Amsterdam, 1081HV, Amsterdam, The Netherlands.
M VerhageDepartment of Functional Genomics, Centre for Neurogenomics and Cognitive Research (CNCR), Neuroscience Campus Amsterdam, VU Medical Centre, VU University Amsterdam, 1081HV, Amsterdam, The Netherlands. m.verhage@vu.nl.
Amsterdam Neuroscience · NLUniversity of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurotransmission and synaptic strength depend on expression of post-synaptic receptors on the cell surface. Post-translational modification of receptors, trafficking to the synapse through the secretory pathway, and subsequent insertion into the synapse involves interaction of the receptor with A-kinase anchor proteins (AKAPs) and scaffolding proteins. Neurobeachin (Nbea), a brain specific AKAP, is required for synaptic surface expression of both glutamate and GABA receptors. Here, we investigated the role of Nbea-dependent targeting of postsynaptic receptors by studying Nbea interaction with synapse-associated protein 102 (SAP102/Dlg3) and protein kinase A subunit II (PKA II). A Nbea mutant lacking the PKA binding domain showed a similar distribution as wild-type Nbea in Nbea null neurons and partially restored GABA receptor surface expression. To understand the relevance of Nbea interaction with SAP102, we analysed SAP102 null mutant mice. Nbea levels were reduced by ~80% in SAP102 null mice, but glutamatergic receptor expression was normal. A single-point mutation in the pleckstrin homology domain of Nbea (E2218R) resulted in loss of binding with SAP102. When expressed in Nbea null neurons, this mutant fully restored GABA receptor surface expression, but not glutamate receptor expression. Our results suggest that the PKA-binding domain is not essential for Nbea's role in receptor targeting and that Nbea targets glutamate and GABA receptors to the synapse via distinct molecular pathways by interacting with specific effector proteins.

Indexed as

Signal TransductionAnimalsCarrier ProteinsCyclic AMP-Dependent Protein KinasesGuanylate KinasesMembrane ProteinsMice, KnockoutNerve Tissue ProteinsNeuronsProtein BindingReceptors, GABAReceptors, GlutamateSynapsesSynaptic TransmissionCarrier ProteinsCyclic AMP-Dependent Protein KinasesDlgh3 protein, mouseGuanylate KinasesMembrane ProteinsNbea protein, mouseNerve Tissue ProteinsReceptors, GABAReceptors, GlutamateAKAPGABA receptorsGlutamate receptorsNeurobeachinSAP102Synapse

Identifiers

PMID25934101
PMCPMC4823379
OpenAlexW2018273238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.